The South African Border Management Authority (BMA) has activated its outbreak preparedness plan in response to the rising cases of Mpox. The National Department of Health has confirmed 13 cases across the country. Yesterday, BMA commissioner Dr Michael Masiapato announced the implementation of a robust screening process at all South African ports of entry. This process aims to detect and respond to potential Mpox cases. This marks the first step as BMA activates the mpox plan.
All individuals entering the country will undergo screening procedures. At airports, the initial phase involves the conveyance operator (the captain) submitting a mandatory health declaration form. This form confirms that no passengers have reported or shown symptoms during the journey. Following the initial screening, travellers will undergo thermal screening to check for elevated temperatures.
Interviews and non-invasive observations
Officials will isolate any traveller with an elevated temperature for further screening. Additionally, BMA port health officers will conduct interviews and non-invasive observations. Masiapato said the BMA thoroughly trains its officers to identify lesions and symptoms. Moreover, the BMA has arranged for ambulance services with the Department of Health to ensure swift referrals to healthcare facilities.
The BMA works closely with district communicable disease facilities. This collaboration ensures prompt reporting and response to suspected cases. Although BMA officials have not yet detected any Mpox cases at ports of entry, the agency has intensified its health education and awareness efforts for travellers.
The BMA echoed the Department of Health’s advice for travellers with chronic conditions. It advised these travellers to continue their medication, as they may experience more severe symptoms. Anyone who suspects they have contracted the virus should seek immediate medical attention. This is especially important for those who have travelled to areas with reported cases.
Sick individuals should self-isolate where possible
The Department of Health has received a batch of Mpox-specific treatment. Doctors are using tecovirimat, also known as TPOXX or ST-246, to treat patients. It is for those experiencing severe health complications due to Mpox. Spokesperson Foster Mohale advised individuals to "self-isolate where possible and avoid contact with people" if they suspect exposure to the disease.
Health officials have confirmed seven cases in KwaZulu-Natal, five in Gauteng, and one in the Western Cape. While the government has not yet acquired any vaccines, Mohale stated that scientists are developing additional treatments. As the situation unfolds, the BMA has activated its mpox plan to adapt to new developments.
Health Minister Dr Joe Phaahla indicated that the country is attempting to obtain vaccines. They are seeking help from World Health Organisation (WHO) member countries with surplus stock. Provincial depots will store and distribute the vaccines. Phaahla said the government is considering additional interventions.
The government has also established the National Advisory Group for Immunisation Technical Working Group for Mpox vaccines. This group is considering how to use the vaccines for pre- and post-exposure administration in high-risk groups.